איקסמפרה 45 מ"ג

Country: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

IXABEPILONE 45 MG

Доступно од:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

АТЦ код:

L01DC04

Фармацеутски облик:

POWDER FOR CONCENTRATE FOR INFUSION

Пут администрације:

I.V

Произведен од:

CORDEN PHARMA LATINA S.P.A., ITALY

Терапеутска група:

IXABEPILONE

Терапеутске индикације:

Ixempra is indicated for the treatment of inoperable locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy:In combination with capecitabine in patients failing prior therapy with a taxane and an anthracycline or for whom further anthracycline therapy is not indicated.As monotherapy in patients failing prior therapy with taxanes, capecitabine and anthracyclines or for whom further anthracycline therapy is not indicated.

Датум одобрења:

2012-01-01